{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:49:49Z","timestamp":1740138589027,"version":"3.37.3"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n de la Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["COV20EDU\/00657"],"award-info":[{"award-number":["COV20EDU\/00657"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Una manera de hacer Europa"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The use of dexamethasone in patients infected with Strongyloides stercoralis can cause severe complications. It is necessary to investigate the relationship between coronavirus disease 2019 (COVID-19) and strongyloidiasis infection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective, longitudinal, descriptive study was undertaken to review all patients admitted with a diagnosis of COVID-19 infection at the Complejo Asistencial Universitario de Salamanca, Spain, during 1 March\u201331 December 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 2567 patients received a diagnosis of COVID-19. Eighty-six patients from endemic areas were included. Seven patients had strongyloidiasis. Five patients were female. The mean age (\u00b1SD) was 39 (\u00b110.8) y. Six patients were Latin-American and only one patient was from Africa. Six patients had previous symptoms compatible with strongyloidiasis infections. Only three patients received dexamethasone (6 mg once daily) for 10 d. In all cases, the clinical courses of the patients were satisfactory. No patient died or was admitted to the ICU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Screening programmes using serological techniques should be implemented in COVID-19 patients to prevent strongyloidiasis. Our study suggested that drugs used against COVID-19 in patients with strongyloidiasis did not affect the evolution of the disease. However, more studies are necessary to elucidate the role of dexamethasone in COVID-19 patients infected with Strongyloides.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/trstmh\/trab152","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T03:13:16Z","timestamp":1631589196000},"page":"440-445","source":"Crossref","is-referenced-by-count":5,"title":["Influence of the drugs used in migrant patients with severe acute respiratory syndrome coronavirus 2 and the development of symptomatic strongyloidiasis"],"prefix":"10.1093","volume":"116","author":[{"given":"Helena","family":"Lorenzo","sequence":"first","affiliation":[{"name":"Servicio de Microbiolog\u00eda y Parasitolog\u00eda, Complejo Asistencial Universitario de Salamanca (CAUSA), Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Carbonell","sequence":"additional","affiliation":[{"name":"Servicio de Medicina Interna, Unidad de Infecciosas, CAUSA, Centro de Investigaci\u00f3n de Enfermedades Tropicales de la Universidad de Salamanca (CIETUS), Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Vicente Santiago","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Diseases Group (e-INTRO), CIETUS, IBSAL, Facultad de Farmacia, Universidad de Salamanca, Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"L\u00f3pez-Bernus","sequence":"additional","affiliation":[{"name":"Servicio de Medicina Interna, Unidad de Infecciosas, CAUSA, CIETUS, IBSAL, Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josu\u00e9","family":"Pendones Ulerio","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda y Parasitolog\u00eda, CAUSA, IBSAL, Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Mu\u00f1oz Bellido","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda y Parasitolog\u00eda, CAUSA, CIETUS, IBSAL, Departamento de Ciencias Biom\u00e9dicas y del Diagn\u00f3stico, Universidad de Salamanca, CSIC, Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Muro","sequence":"additional","affiliation":[{"name":"e-INTRO, CIETUS, IBSAL, Facultad de Farmacia, Universidad de Salamanca, Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2230-1256","authenticated-orcid":false,"given":"Moncef","family":"Belhassen-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Servicio de Medicina Interna, Unidad de Infecciosas, CAUSA, e-INTRO, CIETUS, IBSAL, Salamanca 37007, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"issue":"3","key":"2022050515135028600_bib1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4014\/jmb.2003.03011","article-title":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)","volume":"30","author":"Ahn","year":"2020","journal-title":"J Microbiol Biotechn"},{"key":"2022050515135028600_bib2","doi-asserted-by":"crossref","first-page":"104364","DOI":"10.1016\/j.jcv.2020.104364","article-title":"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China","volume":"127","author":"Zhang","year":"2020","journal-title":"J Clin Virol"},{"issue":"6","key":"2022050515135028600_bib3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/pathogens9060468","article-title":"The global prevalence of Strongyloides stercoralis infection","volume":"9","author":"Buonfrate","year":"2020","journal-title":"Pathogens"},{"issue":"4","key":"2022050515135028600_bib4","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.4269\/ajtmh.20-0699","article-title":"Case report: fisseminated strongyloidiasis in a patient with COVID-19","volume":"103","author":"Lier","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2022050515135028600_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s15010-020-01522-4","article-title":"Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia","volume":"49","author":"Marchese","year":"2021","journal-title":"Infection"},{"key":"2022050515135028600_bib6","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/MD.0000000000000043","article-title":"Relevance of eosinophilia and hyper-IgE in immigrant children","volume":"93","author":"Garcia","year":"2014","journal-title":"Medicine"},{"key":"2022050515135028600_bib7","doi-asserted-by":"crossref","first-page":"101981","DOI":"10.1016\/j.tmaid.2021.101981","article-title":"Risk of Strongyloides hyperinfection syndrome when prescribing dexamethasone in severe COVID-19","volume":"40","author":"","year":"2021","journal-title":"Travel Med Infect Di"},{"key":"2022050515135028600_bib8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jama.2020.13170","article-title":"COVID-19 and dexamethasone","volume":"324","author":"Stauffer","year":"2020","journal-title":"JAMA"},{"key":"2022050515135028600_bib9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1473-3099(19)30289-0","article-title":"Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (strong treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial","volume":"19","author":"Buonfrate","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2022050515135028600_bib10","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4269\/ajtmh.20-1085","article-title":"Dexamethasone and COVID-19: strategies in low- and middle-income countries to tackle steroid-related Strongyloides hyperinfection","volume":"104","author":"Olivera","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"2022050515135028600_bib11","doi-asserted-by":"crossref","first-page":"106248","DOI":"10.1016\/j.ijantimicag.2020.106248","article-title":"A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin","volume":"57","author":"Hellwig","year":"2021","journal-title":"Int J Antimicrob Ag"},{"key":"2022050515135028600_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijid.2020.11.191","article-title":"A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness","volume":"103","author":"Ahmed","year":"2020","journal-title":"Int J Infect Dis"},{"key":"2022050515135028600_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","article-title":"Strongyloides stercoralis in the immunocompromised population","volume":"17","author":"Keiser","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"2022050515135028600_bib14","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4269\/ajtmh.2011.10-0490","article-title":"Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model","volume":"84","author":"Soares","year":"2011","journal-title":"Am J Tropical Med Hyg"},{"key":"2022050515135028600_bib15","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19)","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/5\/440\/43516966\/trab152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/116\/5\/440\/43516966\/trab152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T15:14:26Z","timestamp":1651763666000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/116\/5\/440\/6382411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,10,6]]},"published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trab152","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"type":"print","value":"0035-9203"},{"type":"electronic","value":"1878-3503"}],"subject":[],"published-other":{"date-parts":[[2022,5]]},"published":{"date-parts":[[2021,10,6]]}}}